SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'MTY'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1J37_A_X8ZA801_1 (ANGIOTENSIN CONVERTING ENZYME)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	5 / 11	GLU A 332 HIS A 331 GLU A 376 LYS A 301 TYR A 371	HBI A 500 (-3.2A) FE A 501 ( 3.3A) FE A 501 (-2.1A) MTY A 300 ( 2.9A) MTY A 300 (-3.9A)	1.25A	1j37A-2tohA: undetectable	1j37A-2tohA: 22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1J37_B_X8ZB802_1 (ANGIOTENSIN CONVERTING ENZYME)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	5 / 11	GLU A 332 HIS A 331 GLU A 376 LYS A 301 TYR A 371	HBI A 500 (-3.2A) FE A 501 ( 3.3A) FE A 501 (-2.1A) MTY A 300 ( 2.9A) MTY A 300 (-3.9A)	1.25A	1j37B-2tohA: undetectable	1j37B-2tohA: 22.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1J8U_A_H4BA429_1 (PHENYLALANINE-4-HYDR OXYLASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 7	VAL A 291 LEU A 294 LEU A 295 LEU A 301	HBI A 500 ( 4.6A) HBI A 500 (-4.7A) HBI A 500 (-4.2A) MTY A 300 ( 4.2A)	0.53A	1j8uA-2tohA: 48.7	1j8uA-2tohA: 59.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1KW0_A_H4BA429_1 (PHENYLALANINE-4-HYDR OXYLASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	9 / 12	LEU A 294 LEU A 295 LEU A 301 THR A 312 GLU A 332 HIS A 336 TYR A 371 TRP A 372 GLU A 376	HBI A 500 (-4.7A) HBI A 500 (-4.2A) MTY A 300 ( 4.2A) HBI A 500 ( 4.4A) HBI A 500 (-3.2A) FE A 501 ( 3.4A) MTY A 300 (-3.9A) None FE A 501 (-2.1A)	0.97A	1kw0A-2tohA: 42.9	1kw0A-2tohA: 59.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1KW0_A_H4BA429_1 (PHENYLALANINE-4-HYDR OXYLASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	9 / 12	VAL A 291 LEU A 294 LEU A 295 LEU A 301 THR A 312 GLU A 332 HIS A 336 TRP A 372 GLU A 376	HBI A 500 ( 4.6A) HBI A 500 (-4.7A) HBI A 500 (-4.2A) MTY A 300 ( 4.2A) HBI A 500 ( 4.4A) HBI A 500 (-3.2A) FE A 501 ( 3.4A) None FE A 501 (-2.1A)	0.91A	1kw0A-2tohA: 42.9	1kw0A-2tohA: 59.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MMK_A_H4BA1427_1 (PHENYLALANINE-4-HYDR OXYLASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	8 / 12	LEU A 294 LEU A 295 LEU A 301 GLU A 332 HIS A 336 TYR A 371 TRP A 372 GLU A 376	HBI A 500 (-4.7A) HBI A 500 (-4.2A) MTY A 300 ( 4.2A) HBI A 500 (-3.2A) FE A 501 ( 3.4A) MTY A 300 (-3.9A) None FE A 501 (-2.1A)	1.00A	1mmkA-2tohA: 43.0	1mmkA-2tohA: 59.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MMK_A_H4BA1427_1 (PHENYLALANINE-4-HYDR OXYLASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	8 / 12	VAL A 291 LEU A 294 LEU A 295 LEU A 301 GLU A 332 HIS A 336 TRP A 372 GLU A 376	HBI A 500 ( 4.6A) HBI A 500 (-4.7A) HBI A 500 (-4.2A) MTY A 300 ( 4.2A) HBI A 500 (-3.2A) FE A 501 ( 3.4A) None FE A 501 (-2.1A)	0.94A	1mmkA-2tohA: 43.0	1mmkA-2tohA: 59.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MMT_A_H4BA1426_1 (PHENYLALANINE-4-HYDR OXYLASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	8 / 11	LEU A 294 LEU A 295 LEU A 301 THR A 312 GLU A 332 HIS A 336 TYR A 371 GLU A 376	HBI A 500 (-4.7A) HBI A 500 (-4.2A) MTY A 300 ( 4.2A) HBI A 500 ( 4.4A) HBI A 500 (-3.2A) FE A 501 ( 3.4A) MTY A 300 (-3.9A) FE A 501 (-2.1A)	0.86A	1mmtA-2tohA: 43.0	1mmtA-2tohA: 59.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MMT_A_H4BA1426_1 (PHENYLALANINE-4-HYDR OXYLASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	8 / 11	VAL A 291 LEU A 294 LEU A 295 LEU A 301 THR A 312 GLU A 332 HIS A 336 GLU A 376	HBI A 500 ( 4.6A) HBI A 500 (-4.7A) HBI A 500 (-4.2A) MTY A 300 ( 4.2A) HBI A 500 ( 4.4A) HBI A 500 (-3.2A) FE A 501 ( 3.4A) FE A 501 (-2.1A)	0.84A	1mmtA-2tohA: 43.0	1mmtA-2tohA: 59.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	5 / 8	GLN A 347 PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None None MTY A 300 ( 3.9A)	1.40A	2eilP-2tohA: undetectable 2eilW-2tohA: undetectable	2eilP-2tohA: 21.19 2eilW-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X8Z_A_X8ZA1615_1 (ANGIOTENSIN CONVERTING ENZYME)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	5 / 11	GLU A 332 HIS A 331 GLU A 376 LYS A 301 TYR A 371	HBI A 500 (-3.2A) FE A 501 ( 3.3A) FE A 501 (-2.1A) MTY A 300 ( 2.9A) MTY A 300 (-3.9A)	1.23A	2x8zA-2tohA: undetectable	2x8zA-2tohA: 22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_C_CHDC1265_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.25A	2y69C-2tohA: undetectable 2y69J-2tohA: undetectable	2y69C-2tohA: 21.19 2y69J-2tohA: 11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_P_CHDP1265_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.18A	2y69P-2tohA: undetectable 2y69W-2tohA: undetectable	2y69P-2tohA: 21.19 2y69W-2tohA: 11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 6	GLN A 347 PHE A 348 PHE A 345 PHE A 309	None None None MTY A 300 ( 3.9A)	1.09A	3ablP-2tohA: undetectable 3ablW-2tohA: undetectable	3ablP-2tohA: 21.19 3ablW-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.27A	3abmC-2tohA: undetectable 3abmJ-2tohA: undetectable	3abmC-2tohA: 21.19 3abmJ-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.21A	3abmP-2tohA: undetectable 3abmW-2tohA: undetectable	3abmP-2tohA: 21.19 3abmW-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.25A	3ag3C-2tohA: undetectable 3ag3J-2tohA: undetectable	3ag3C-2tohA: 21.19 3ag3J-2tohA: 11.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PAH_A_LNRA600_1 (PHENYLALANINE HYDROXYLASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 6	HIS A 331 HIS A 336 TYR A 371 GLU A 376	FE A 501 ( 3.3A) FE A 501 ( 3.4A) MTY A 300 (-3.9A) FE A 501 (-2.1A)	0.53A	4pahA-2tohA: 48.1	4pahA-2tohA: 62.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RMJ_A_NCAA402_0 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 7	LEU A 340 LEU A 304 ILE A 352 ASP A 351	None MTY A 300 ( 3.9A) None None	0.86A	4rmjA-2tohA: undetectable	4rmjA-2tohA: 24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RYA_A_MTLA501_1 (ABC TRANSPORTER SUBSTRATE BINDING PROTEIN (SORBITOL))	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	3 / 3	GLU A 332 TYR A 371 GLU A 376	HBI A 500 (-3.2A) MTY A 300 (-3.9A) FE A 501 (-2.1A)	0.82A	4ryaA-2tohA: undetectable	4ryaA-2tohA: 23.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	5 / 6	GLN A 347 PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None None MTY A 300 ( 3.9A)	1.41A	5b1bC-2tohA: undetectable 5b1bJ-2tohA: undetectable	5b1bC-2tohA: 21.19 5b1bJ-2tohA: 11.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5PAH_A_LDPA600_1 (PHENYLALANINE 4-MONOOXYGENASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 4	HIS A 331 HIS A 336 TYR A 371 GLU A 376	FE A 501 ( 3.3A) FE A 501 ( 3.4A) MTY A 300 (-3.9A) FE A 501 (-2.1A)	0.53A	5pahA-2tohA: 47.8	5pahA-2tohA: 62.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.23A	5wauC-2tohA: undetectable 5wauJ-2tohA: undetectable	5wauC-2tohA: 21.19 5wauJ-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_C_CHDC308_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.20A	5wauc-2tohA: undetectable 5wauj-2tohA: undetectable	5wauc-2tohA: 21.19 5wauj-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_C_CHDC308_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.16A	5xdqC-2tohA: undetectable 5xdqJ-2tohA: undetectable	5xdqC-2tohA: 21.19 5xdqJ-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 5	PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.19A	5xdqP-2tohA: undetectable 5xdqW-2tohA: undetectable	5xdqP-2tohA: 21.19 5xdqW-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	5 / 6	GLN A 347 PHE A 348 PHE A 345 LEU A 340 PHE A 309	None None None None MTY A 300 ( 3.9A)	1.48A	5z85P-2tohA: undetectable 5z85W-2tohA: undetectable	5z85P-2tohA: 21.19 5z85W-2tohA: 11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	4 / 6	GLN A 347 PHE A 348 LEU A 340 PHE A 309	None None None MTY A 300 ( 3.9A)	1.23A	6nmpC-2tohA: undetectable 6nmpJ-2tohA: undetectable	6nmpC-2tohA: 21.19 6nmpJ-2tohA: 11.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6PAH_A_DAHA600_1 (PHENYLALANINE 4-MONOOXYGENASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	5 / 6	LEU A 294 PRO A 327 HIS A 331 HIS A 336 TYR A 371	HBI A 500 (-4.7A) HBI A 500 (-4.1A) FE A 501 ( 3.3A) FE A 501 ( 3.4A) MTY A 300 (-3.9A)	0.74A	6pahA-2tohA: 47.8	6pahA-2tohA: 62.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6PAH_A_DAHA600_1 (PHENYLALANINE 4-MONOOXYGENASE)	2toh	TYROSINE 3-MONOOXYGENASE (Rattus norvegicus)	5 / 6	PRO A 327 HIS A 331 HIS A 336 TYR A 371 GLU A 376	HBI A 500 (-4.1A) FE A 501 ( 3.3A) FE A 501 ( 3.4A) MTY A 300 (-3.9A) FE A 501 (-2.1A)	0.47A	6pahA-2tohA: 47.8	6pahA-2tohA: 62.22

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1J37_A_X8ZA801_1","ANGIOTENSIN CONVERTING ENZYME","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",5,"GLU A 332;HIS A 331;GLU A 376;LYS A 301;TYR A 371","HBI A 500 (-3.2A); FE A 501 ( 3.3A); FE A 501 (-2.1A);MTY A 300 ( 2.9A);MTY A 300 (-3.9A)","1.25A","1j37A-2tohA:undetectable",null],["1J37_B_X8ZB802_1","ANGIOTENSIN CONVERTING ENZYME","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",5,"GLU A 332;HIS A 331;GLU A 376;LYS A 301;TYR A 371","HBI A 500 (-3.2A); FE A 501 ( 3.3A); FE A 501 (-2.1A);MTY A 300 ( 2.9A);MTY A 300 (-3.9A)","1.25A","1j37B-2tohA:undetectable","1j37A-2tohA:22.41"],["1J8U_A_H4BA429_1","PHENYLALANINE-4-HYDROXYLASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"VAL A 291;LEU A 294;LEU A 295;LEU A 301","HBI A 500 ( 4.6A);HBI A 500 (-4.7A);HBI A 500 (-4.2A);MTY A 300 ( 4.2A)","0.53A","1j8uA-2tohA:48.7","1j37B-2tohA:22.41"],["1KW0_A_H4BA429_1","PHENYLALANINE-4-HYDROXYLASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",9,"LEU A 294;LEU A 295;LEU A 301;THR A 312;GLU A 332;HIS A 336;TYR A 371;TRP A 372;GLU A 376","HBI A 500 (-4.7A);HBI A 500 (-4.2A);MTY A 300 ( 4.2A);HBI A 500 ( 4.4A);HBI A 500 (-3.2A); FE A 501 ( 3.4A);MTY A 300 (-3.9A);None; FE A 501 (-2.1A)","0.97A","1kw0A-2tohA:42.9","1j8uA-2tohA:59.47"],["1KW0_A_H4BA429_1","PHENYLALANINE-4-HYDROXYLASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",9,"VAL A 291;LEU A 294;LEU A 295;LEU A 301;THR A 312;GLU A 332;HIS A 336;TRP A 372;GLU A 376","HBI A 500 ( 4.6A);HBI A 500 (-4.7A);HBI A 500 (-4.2A);MTY A 300 ( 4.2A);HBI A 500 ( 4.4A);HBI A 500 (-3.2A); FE A 501 ( 3.4A);None; FE A 501 (-2.1A)","0.91A","1kw0A-2tohA:42.9","1kw0A-2tohA:59.47"],["1MMK_A_H4BA1427_1","PHENYLALANINE-4-HYDROXYLASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",8,"LEU A 294;LEU A 295;LEU A 301;GLU A 332;HIS A 336;TYR A 371;TRP A 372;GLU A 376","HBI A 500 (-4.7A);HBI A 500 (-4.2A);MTY A 300 ( 4.2A);HBI A 500 (-3.2A); FE A 501 ( 3.4A);MTY A 300 (-3.9A);None; FE A 501 (-2.1A)","1.00A","1mmkA-2tohA:43.0","1kw0A-2tohA:59.47"],["1MMK_A_H4BA1427_1","PHENYLALANINE-4-HYDROXYLASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",8,"VAL A 291;LEU A 294;LEU A 295;LEU A 301;GLU A 332;HIS A 336;TRP A 372;GLU A 376","HBI A 500 ( 4.6A);HBI A 500 (-4.7A);HBI A 500 (-4.2A);MTY A 300 ( 4.2A);HBI A 500 (-3.2A); FE A 501 ( 3.4A);None; FE A 501 (-2.1A)","0.94A","1mmkA-2tohA:43.0","1mmkA-2tohA:59.47"],["1MMT_A_H4BA1426_1","PHENYLALANINE-4-HYDROXYLASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",8,"LEU A 294;LEU A 295;LEU A 301;THR A 312;GLU A 332;HIS A 336;TYR A 371;GLU A 376","HBI A 500 (-4.7A);HBI A 500 (-4.2A);MTY A 300 ( 4.2A);HBI A 500 ( 4.4A);HBI A 500 (-3.2A); FE A 501 ( 3.4A);MTY A 300 (-3.9A); FE A 501 (-2.1A)","0.86A","1mmtA-2tohA:43.0","1mmkA-2tohA:59.47"],["1MMT_A_H4BA1426_1","PHENYLALANINE-4-HYDROXYLASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",8,"VAL A 291;LEU A 294;LEU A 295;LEU A 301;THR A 312;GLU A 332;HIS A 336;GLU A 376","HBI A 500 ( 4.6A);HBI A 500 (-4.7A);HBI A 500 (-4.2A);MTY A 300 ( 4.2A);HBI A 500 ( 4.4A);HBI A 500 (-3.2A); FE A 501 ( 3.4A); FE A 501 (-2.1A)","0.84A","1mmtA-2tohA:43.0","1mmtA-2tohA:59.47"],["2EIL_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",5,"GLN A 347;PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;None;MTY A 300 ( 3.9A)","1.40A","2eilP-2tohA:undetectable;2eilW-2tohA:undetectable","1mmtA-2tohA:59.47"],["2X8Z_A_X8ZA1615_1","ANGIOTENSIN CONVERTING ENZYME","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",5,"GLU A 332;HIS A 331;GLU A 376;LYS A 301;TYR A 371","HBI A 500 (-3.2A); FE A 501 ( 3.3A); FE A 501 (-2.1A);MTY A 300 ( 2.9A);MTY A 300 (-3.9A)","1.23A","2x8zA-2tohA:undetectable","2eilP-2tohA:21.19;2eilW-2tohA:11.14"],["2Y69_C_CHDC1265_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.25A","2y69C-2tohA:undetectable;2y69J-2tohA:undetectable","2x8zA-2tohA:22.57"],["2Y69_P_CHDP1265_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.18A","2y69P-2tohA:undetectable;2y69W-2tohA:undetectable","2y69C-2tohA:21.19;2y69J-2tohA:11.95"],["3ABL_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"GLN A 347;PHE A 348;PHE A 345;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.09A","3ablP-2tohA:undetectable;3ablW-2tohA:undetectable","2y69P-2tohA:21.19;2y69W-2tohA:11.95"],["3ABM_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.27A","3abmC-2tohA:undetectable;3abmJ-2tohA:undetectable","3ablP-2tohA:21.19;3ablW-2tohA:11.14"],["3ABM_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.21A","3abmP-2tohA:undetectable;3abmW-2tohA:undetectable","3abmC-2tohA:21.19;3abmJ-2tohA:11.14"],["3AG3_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.25A","3ag3C-2tohA:undetectable;3ag3J-2tohA:undetectable","3abmP-2tohA:21.19;3abmW-2tohA:11.14"],["4PAH_A_LNRA600_1","PHENYLALANINE HYDROXYLASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"HIS A 331;HIS A 336;TYR A 371;GLU A 376"," FE A 501 ( 3.3A); FE A 501 ( 3.4A);MTY A 300 (-3.9A); FE A 501 (-2.1A)","0.53A","4pahA-2tohA:48.1","3ag3C-2tohA:21.19;3ag3J-2tohA:11.14"],["4RMJ_A_NCAA402_0","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"LEU A 340;LEU A 304;ILE A 352;ASP A 351","None;MTY A 300 ( 3.9A);None;None","0.86A","4rmjA-2tohA:undetectable","4pahA-2tohA:62.22"],["4RYA_A_MTLA501_1","ABC TRANSPORTER SUBSTRATE BINDING PROTEIN (SORBITOL)","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",3,"GLU A 332;TYR A 371;GLU A 376","HBI A 500 (-3.2A);MTY A 300 (-3.9A); FE A 501 (-2.1A)","0.82A","4ryaA-2tohA:undetectable","4rmjA-2tohA:24.40"],["5B1B_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",5,"GLN A 347;PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;None;MTY A 300 ( 3.9A)","1.41A","5b1bC-2tohA:undetectable;5b1bJ-2tohA:undetectable","4ryaA-2tohA:23.34"],["5PAH_A_LDPA600_1","PHENYLALANINE 4-MONOOXYGENASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"HIS A 331;HIS A 336;TYR A 371;GLU A 376"," FE A 501 ( 3.3A); FE A 501 ( 3.4A);MTY A 300 (-3.9A); FE A 501 (-2.1A)","0.53A","5pahA-2tohA:47.8","5b1bC-2tohA:21.19;5b1bJ-2tohA:11.14"],["5WAU_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.23A","5wauC-2tohA:undetectable;5wauJ-2tohA:undetectable","5pahA-2tohA:62.22"],["5WAU_C_CHDC308_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.20A","5wauc-2tohA:undetectable;5wauj-2tohA:undetectable","5wauC-2tohA:21.19;5wauJ-2tohA:11.14"],["5XDQ_C_CHDC308_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.16A","5xdqC-2tohA:undetectable;5xdqJ-2tohA:undetectable","5wauc-2tohA:21.19;5wauj-2tohA:11.14"],["5XDQ_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.19A","5xdqP-2tohA:undetectable;5xdqW-2tohA:undetectable","5xdqC-2tohA:21.19;5xdqJ-2tohA:11.14"],["5Z85_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",5,"GLN A 347;PHE A 348;PHE A 345;LEU A 340;PHE A 309","None;None;None;None;MTY A 300 ( 3.9A)","1.48A","5z85P-2tohA:undetectable;5z85W-2tohA:undetectable","5xdqP-2tohA:21.19;5xdqW-2tohA:11.14"],["6NMP_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",4,"GLN A 347;PHE A 348;LEU A 340;PHE A 309","None;None;None;MTY A 300 ( 3.9A)","1.23A","6nmpC-2tohA:undetectable;6nmpJ-2tohA:undetectable","5z85P-2tohA:21.19;5z85W-2tohA:11.14"],["6PAH_A_DAHA600_1","PHENYLALANINE 4-MONOOXYGENASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",5,"LEU A 294;PRO A 327;HIS A 331;HIS A 336;TYR A 371","HBI A 500 (-4.7A);HBI A 500 (-4.1A); FE A 501 ( 3.3A); FE A 501 ( 3.4A);MTY A 300 (-3.9A)","0.74A","6pahA-2tohA:47.8","6nmpC-2tohA:21.19;6nmpJ-2tohA:11.14"],["6PAH_A_DAHA600_1","PHENYLALANINE 4-MONOOXYGENASE","2toh","TYROSINE 3-MONOOXYGENASE","Rattus norvegicus",5,"PRO A 327;HIS A 331;HIS A 336;TYR A 371;GLU A 376","HBI A 500 (-4.1A); FE A 501 ( 3.3A); FE A 501 ( 3.4A);MTY A 300 (-3.9A); FE A 501 (-2.1A)","0.47A","6pahA-2tohA:47.8","6pahA-2tohA:62.22"]]